Integumen builds out Labskin AI platform with RinoCloud acquisition
Life sciences group Integumen PLC (LON:SKIN) chief executive Gerry Brandon speaks to Proactive London’s Andrew Scott following the announcement they’ve agreed to buy scientific data management specialist, RinoCloud.
Integumen‘s been using RinoCloud’s technology in its development of Labskin AI – an extension of Integumen’s laboratory-grown skin product which provides real-time test results to skincare, wound care, pharma, healthcare and personal care companies.
Source Link www.proactiveinvestors.co.uk
Gerard J Brandon Twitter Account @gjbrandon
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned